The major factors driving the growth of this market include increasing funding for cell-based research, growing applications of gene expression, and a rising preference for cell-based assays.
The report “Reporter Gene Assay Market by Reagents & Assay kits (Luciferase, Green Fluorescent Protein, â-glucuronidase, â-galactosidase), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End Users, Region – Global Forecast to 2024″, The reporter gene assays market is expected to reach USD 2.6 billion by 2024 from an estimated USD 1.6 billion in 2019, at a CAGR of 10.1%.
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
By application, the cell signaling pathways segment is expected to grow at the highest CAGR during the forecast period (2019-2024)”
Based on application, the reporter gene assays market is segmented into gene regulation, protein interaction, cell signaling pathways, and promotor structural & functional analysis. In 2019, the cell signaling pathways segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is attributed to its importance in several cellular functionalities (such as cell differentiation, cell fate determination, and cell growth) and advanced applications of cell signaling in life science sectors (such as biotechnology, molecular biology, and microbiology).
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20053198
Recent Developments:
# In 2018, Thermo Fisher acquired Advanced Bioprocessing business from BD, to expand Thermo Fisher Scientific’s cell-culture media products and strong technical services program.
# In 2017, Becton, Dickinson and Company acquired C.R Bard (US). This acquisition advanced BD’s product offerings and global reach.
# In 2018, Merck opened a new 3,800-square-meter laboratory in Singapore.
# In 2018, Thermo Fisher Scientific (US) opened its Bioprocess design center in Shanghai.
By product, the Assay kits segment to dominate the reporter gene assays market in 2019
On the basis of product, the market is broadly split into reagents and assay kits. The assay kits segment is expected to account for the larger share of the reporter gene assays market in 2019. The large share of the assay kits segment can be attributed to their repeated use in gene expression studies and signaling pathway analysis during gene transcription or translation levels. Assay kits are preferred over standalone reagents in cases where a validated protocol for assay development is available. Assay kits not only save time but also offer technological advantages, easy availability, and greater convenience.
Critical questions the report answers:
# Where will all these developments take the industry in the mid-to-long term?
# What are the major end users of reporter gene assays?
# What are the application areas of the reporter gene assays?
# Which are the most commonly used reporter gene assays kits?
# What is the global scenario of the reporter gene assays market?
North America to hold the largest regional market share in 2019
North America is expected to account for the largest share of the reporter gene assays market in 2019, followed by Europe. The large share of North America in the global market can be attributed to the growing academic and government investments in genomics and proteomics research; rising demand for cell-based assays in research; increasing focus on cell-based therapeutics; and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=20053198
The prominent players in the reporter gene assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Danaher Corporation (US), Geno Technology (US), Genecopoeia, Inc. (US), InvivoGen (France), PromoCell (Germany), Becton, Dickinson and Company (US), Biotium, Inc. (US), Canvax (Spain), LI-COR, Inc. (US), System Biosciences, LLC (US), Indigo Biosciences, Inc. (US), BioThema (Sweden), Takara Bio Inc (US), BioAssay Systems (US), Cell Biolabs, Inc. (US), BPS Bioscience, Inc (US), Biosynth AG (Switzerland), and Cayman Chemical (US).
